Michael Gelband’s Procter & Gamble PG Stock Holding History

Michael Gelband’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,000	Closed	-$2.52M	–	1877
2024 Q4	$2.52M	Buy	15,000 +13,800	+1,150%	+$2.35M	0.02%	642
2024 Q3	$208K	Buy	+1,200	New	+$204K	﹤0.01%	1446

Other funds holding PG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Michael Gelband's PG Position: Q2 2026 in Review

Michael Gelband sold out of Procter & Gamble (PG) in Q2 2026, closing a stake of 92,607 shares — an estimated $13.4M sold.

Michael Gelband first reported a position in PG in Q4 2018 and held it in 23 quarters. The position peaked at $73.1M in Q3 2025. 4,001 funds tracked by Wall St. Rank hold PG as of Q2 2026.

Michael Gelband reported no remaining Procter & Gamble position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 92,607 Procter & Gamble shares in Q2 2026, an estimated $13.4M.
Michael Gelband first reported a position in Procter & Gamble in Q4 2018 and held it in 23 quarters.
Michael Gelband's Procter & Gamble position peaked at $73.1M in Q3 2025.
4,001 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.